1. Home
  2. STWD vs DNTH Comparison

STWD vs DNTH Comparison

Compare STWD & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$15.67

Market Cap

6.2B

Sector

Real Estate

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$106.95

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
DNTH
Founded
2009
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.9B
IPO Year
2009
2018

Fundamental Metrics

Financial Performance
Metric
STWD
DNTH
Price
$15.67
$106.95
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$20.00
$121.00
AVG Volume (30 Days)
3.6M
544.6K
Earning Date
05-08-2026
05-06-2026
Dividend Yield
10.64%
N/A
EPS Growth
4.55
N/A
EPS
0.15
N/A
Revenue
$1,844,289,000.00
$2,036,000.00
Revenue This Year
$283.44
N/A
Revenue Next Year
$17.66
$29.48
P/E Ratio
$105.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$32.28
52 Week High
$20.62
$117.88

Technical Indicators

Market Signals
Indicator
STWD
DNTH
Relative Strength Index (RSI) 37.60 44.50
Support Level $15.50 $101.19
Resistance Level $16.89 $107.99
Average True Range (ATR) 0.26 4.59
MACD -0.02 -0.85
Stochastic Oscillator 10.48 26.26

Price Performance

Historical Comparison
STWD
DNTH

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: